Follow-up
intrahepatic recurrence
RECURRENCE
No adjuvant treatment will be used after surgery. All patients will be followed up every 3–6 months for up to 5 years after operation. Follow-up assessment will include: liver function (clinical assessment of Child’s grade, complete blood count, liver, and coagulation profile); recurrence (based on serum Patients with intrahepatic recurrence will be managed by laparoscopic re-resection for the LMH group or open re-resection for the OMH group when considered feasible. For patients in whom re-resection is not possible, thermal ablation, transarterial chemoembolization, or salvage liver transplant will be offered according to the decision of the multidisciplinary team.